Form 8-K - Current report:
SEC Accession No. 0001641172-25-009744
Filing Date
2025-05-12
Accepted
2025-05-12 17:00:12
Documents
15
Period of Report
2025-05-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38953
2 EX-99.1 ex99-1.htm EX-99.1 10605
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4129
  Complete submission text file 0001641172-25-009744.txt   238542

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hepa-20250509.xsd EX-101.SCH 3027
5 XBRL LABEL FILE hepa-20250509_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE hepa-20250509_pre.xml EX-101.PRE 24603
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3868
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 25935814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)